Duchenne Drug Delayed After Outrage Over Price
Many Duchenne muscular dystrophy patients in the U.S. have imported a medicine called deflazacort for about $1,200 a year. A brand-name version just approved for sale in America costs $89,000.
Read more on NPR
February 15, 2017 at 02:15AM
Health Care
Thứ Tư, 15 tháng 2, 2017
Đăng ký:
Đăng Nhận xét (Atom)
0 nhận xét:
Đăng nhận xét